A detailed history of Federated Hermes, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 493,585 shares of ILMN stock, worth $67.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
493,585
Previous 530,439 6.95%
Holding current value
$67.1 Million
Previous $55.4 Million 16.25%
% of portfolio
0.15%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$105.28 - $135.9 $3.88 Million - $5.01 Million
-36,854 Reduced 6.95%
493,585 $64.4 Million
Q2 2024

Aug 08, 2024

BUY
$101.05 - $133.57 $44.8 Million - $59.3 Million
443,720 Added 511.68%
530,439 $55.4 Million
Q1 2024

May 14, 2024

BUY
$127.73 - $147.2 $10.7 Million - $12.3 Million
83,775 Added 2845.62%
86,719 $11.9 Million
Q4 2023

Jan 31, 2024

SELL
$92.79 - $142.53 $3.76 Million - $5.78 Million
-40,547 Reduced 93.23%
2,944 $409,000
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $11.7 Million - $17.4 Million
-90,610 Reduced 67.57%
43,491 $5.97 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $1.04 Million - $1.32 Million
-5,655 Reduced 4.05%
134,101 $25.1 Million
Q1 2023

May 08, 2023

SELL
$193.75 - $232.55 $12.3 Million - $14.7 Million
-63,243 Reduced 31.15%
139,756 $32.5 Million
Q4 2022

Feb 13, 2023

SELL
$187.24 - $242.74 $688,107 - $892,069
-3,675 Reduced 1.78%
202,999 $41 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $8.03 Million - $10.3 Million
-45,318 Reduced 17.98%
206,674 $39.4 Million
Q2 2022

Aug 15, 2022

SELL
$181.58 - $368.0 $1.13 Million - $2.29 Million
-6,234 Reduced 2.41%
251,992 $46.5 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $55.4 Million - $77.2 Million
182,272 Added 239.98%
258,226 $90.2 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $5.15 Million - $6.26 Million
14,835 Added 24.27%
75,954 $28.9 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $2.48 Million - $3.21 Million
6,118 Added 11.12%
61,119 $24.8 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $11,930 - $15,408
32 Added 0.06%
55,001 $26 Million
Q1 2021

May 13, 2021

BUY
$361.28 - $504.76 $1.72 Million - $2.4 Million
4,764 Added 9.49%
54,969 $21.1 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $3.76 Million - $4.76 Million
12,843 Added 34.37%
50,205 $18.6 Million
Q3 2020

Nov 12, 2020

SELL
$268.51 - $400.74 $25.2 Million - $37.6 Million
-93,798 Reduced 71.51%
37,362 $11.5 Million
Q2 2020

Aug 13, 2020

SELL
$256.46 - $373.01 $1.78 Million - $2.59 Million
-6,951 Reduced 5.03%
131,160 $48.6 Million
Q1 2020

May 13, 2020

SELL
$209.2 - $335.53 $10.4 Million - $16.7 Million
-49,881 Reduced 26.53%
138,111 $37.7 Million
Q4 2019

Feb 14, 2020

SELL
$288.29 - $335.49 $1.4 Million - $1.63 Million
-4,846 Reduced 2.51%
187,992 $62.4 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $67 Million - $94.9 Million
-251,003 Reduced 56.55%
192,838 $58.7 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $1.37 Million - $1.68 Million
4,554 Added 1.04%
443,841 $163 Million
Q1 2019

May 10, 2019

SELL
$272.57 - $321.18 $14.7 Million - $17.3 Million
-53,768 Reduced 10.91%
439,287 $136 Million
Q4 2018

Feb 13, 2019

SELL
$272.46 - $366.54 $8.04 Million - $10.8 Million
-29,508 Reduced 5.65%
493,055 $148 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $2.78 Million - $3.65 Million
9,952 Added 1.94%
522,563 $192 Million
Q2 2018

Aug 10, 2018

BUY
$228.17 - $292.07 $4.64 Million - $5.94 Million
20,324 Added 4.13%
512,611 $143 Million
Q1 2018

May 09, 2018

BUY
$209.54 - $253.91 $99.9 Million - $121 Million
476,848 Added 3088.59%
492,287 $116 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $1.92 Million - $2.19 Million
9,516 Added 160.66%
15,439 $0
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $1.02 Million - $1.27 Million
5,923
5,923 $1.18 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.